Concepedia

Author

Paul de Souza

Western Sydney UniversityORCID

Also Known As

De Souza, Paul, Elizabeth Hovey, O'Sullivan, Joseph M., P De Souza, P de Souza, P. De Souza, P. de Souza, P.D.E. SOUZA, PDe Souza, Paul DE SOUZA

244

Publications

14.7K

Citations

45

H-Index

74

Concepts

All Affiliations

Western Sydney UniversityUNSW SydneyLiverpool HospitalIngham InstituteCamden and Campbelltown Hospitals
PD

About

Paul de Souza is an author at Western Sydney University specializing in medicine, oncology, and cancer therapeutics.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

18

25

3K

2

Engineering

3

3

151

3

Health Sciences

2

2

57

4

Biomolecular Engineering

2

2

87

5

Biomedical Engineering

1

1

22

Paul de Souza

×

80

Publications

13.1K

Citations

38

H-Index

YearCitations

Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy

Charles J. Ryan, Matthew R. Smith, Johann S. de Bono,

New England Journal of Medicine

2012

2.8K

Pazopanib versus Sunitinib in Metastatic Renal-Cell Carcinoma

Robert J. Motzer, Thomas E. Hutson, David Cella,

New England Journal of Medicine

2013

1.9K

Effect of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma

David A. Reardon, Alba A. Brandes, Antonio Omuro,

JAMA Oncology

2020

1.4K

Abiraterone acetate plus prednisone versus placebo plus prednisone in chemotherapy-naive men with metastatic castration-resistant prostate cancer (COU-AA-302): final overall survival analysis of a randomised, double-blind, placebo-controlled phase 3 study

Charles J. Ryan, Matthew R. Smith, Karim Fizazi,

The Lancet Oncology

2015

1.3K

Zoledronic Acid Versus Placebo in the Treatment of Skeletal Metastases in Patients With Lung Cancer and Other Solid Tumors: A Phase III, Double-Blind, Randomized Trial—The Zoledronic Acid Lung Cancer and Other Solid Tumors Study Group

Lee S. Rosen, David Gordon, Simon Tchekmedyian,

Journal of Clinical Oncology

2003

726

Long‐term efficacy and safety of zoledronic acid in the treatment of skeletal metastases in patients with nonsmall cell lung carcinoma and other solid tumors

Lee S. Rosen, David Gordon, N. Simon Tchekmedyian,

Cancer

2004

716

OS10.3 Randomized Phase 3 Study Evaluating the Efficacy and Safety of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma: CheckMate 143

David A. Reardon, Antonio Omuro, Alba A. Brandes,

Neuro-Oncology

2017

315

Updated Interim Efficacy Analysis and Long-term Safety of Abiraterone Acetate in Metastatic Castration-resistant Prostate Cancer Patients Without Prior Chemotherapy (COU-AA-302)

Dana E. Rathkopf, Matthew R. Smith, Johann S. de Bono,

European Urology

2014

271

Effect of temsirolimus versus interferon-α on outcome of patients with advanced renal cell carcinoma of different tumor histologies

Janice P. Dutcher, Paul de Souza, David F. McDermott,

Medical Oncology

2009

256

Correlation of PD-L1 Tumor Expression and Treatment Outcomes in Patients with Renal Cell Carcinoma Receiving Sunitinib or Pazopanib: Results from COMPARZ, a Randomized Controlled Trial

Toni K. Choueiri, David J. Figueroa, André P. Fay,

Clinical Cancer Research

2014

242

Page 1